---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007281"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:51:36.912206+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ZyVersa files Section 205 petition to validate charter amendment after Boxed decision uncertainty

## Summary
- Filed petition in Delaware Chancery on March 9, 2023 seeking validation of Second Amended and Restated Certificate of Incorporation and all shares issued.
- Uncertainty arose from Boxed decision questioning whether separate class vote was required for reduction of authorized shares from 220M to 110M.
- Court granted expedited proceedings; final hearing set for March 29, 2023 at 11:00 a.m. ET.
- Company had 9,211,922 shares outstanding as of petition date; all shares remain below authorized limits.
- If validation not granted, could affect ability to raise capital and Nasdaq listing.

## SEC filing metadata
- accession: 0001493152-23-007281
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315223007281/0001493152-23-007281-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315223007281/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007281
- JSON: https://secwatch.observer/filing/0001493152-23-007281.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007281.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.